The design and optimization of a series of 2-(pyridin-2-yl)-1H-benzimidazole compounds as allosteric glucokinase activators

…, N Hashimoto, C Nakama, K Kamata, K Sasaki…

Index: Takahashi, Keiji; Hashimoto, Noriaki; Nakama, Chisato; Kamata, Kenji; Sasaki, Kaori; Yoshimoto, Riki; Ohyama, Sumika; Hosaka, Hideka; Maruki, Hiroko; Nagata, Yasufumi; Eiki, Jun-ichi; Nishimura, Teruyuki Bioorganic and Medicinal Chemistry, 2009 , vol. 17, # 19 p. 7042 - 7051

Full Text: HTML

Citation Number: 35

Abstract

The optimization of a series of benzimidazole glucokinase activators is described. We identified a novel and potent achiral benzimidazole derivative as an allosteric GK activator. This activator was designed and synthesized via removal of the chiral center of the lead compound, 6-(N-acylpyrrolidin-2-yl) benzimidazole. The activator exhibited good PK profiles in rats and dogs, and significant hypoglycemic efficacy at 1mg/kg po dosing in a rat OGTT ...

Related Articles:

Synthesis and SAR of selective small molecule neuropeptide Y Y2 receptor antagonists

[Mittapalli, Gopi Kumar; Vellucci, Danielle; Yang, Jun; Toussaint, Marion; Brothers, Shaun P.; Wahlestedt, Claes; Roberts, Edward Bioorganic and Medicinal Chemistry Letters, 2012 , vol. 22, # 12 p. 3916 - 3920]

More Articles...